China Universal Asset Management Co., Ltd. Adaptimmune Therapeutics PLC Transaction History

China Universal Asset Management Co., Ltd.

$1.03 Billion
Q4 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$0.73 - $1.04 $2,457 - $3,501	3,367 Added 175.55%	5,285 $4,000
Q3 2023 Oct 30, 2023	BUY	$0.73 - $1.04 $2,457 - $3,501	3,367 Added 175.55%	5,285 $4,000
Q2 2023 May 21, 2024	SELL	$0.9 - $1.51 $46 - $78	-52 Reduced 2.64%	1,918 $1,000
Q2 2023 Jul 27, 2023	SELL	$0.9 - $1.51 $46 - $78	-52 Reduced 2.64%	1,918 $2,000
Q1 2023 May 21, 2024	BUY	$1.06 - $2.16 $531 - $1,082	501 Added 34.1%	1,970 $2,000
Q1 2023 Apr 27, 2023	BUY	$1.06 - $2.16 $531 - $1,082	501 Added 34.1%	1,970 $2,000
Q4 2022 May 21, 2024	BUY	$1.05 - $2.53 $1,542 - $3,716	1,469 New	1,469 $2,000
Q4 2022 Jan 31, 2023	BUY	$1.05 - $2.53 $130 - $313	124 Added 9.22%	1,469 $2,000
Q3 2022 Oct 21, 2022	BUY	$1.06 - $2.41 $1,425 - $3,241	1,345 New	1,345 $1,000

Others Institutions Holding ADAP

# of Institutions

Shares Held

145M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$22.6 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$16.4 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$10.2 Million
1.24% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$7.98 Million
0.46% of portfolio
Baillie Gifford & CO

11.8M
Shares

$7.09 Million
0.01% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $98M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account